...
首页> 外文期刊>Pharmacological reports: PR >Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists.
【24h】

Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists.

机译:DSP-4和5,7-DHT引起的新生儿共病对多巴胺D2受体激动剂产生了成年行为敏化作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To assess the possible modulatory effects of noradrenergic and serotoninergic neurons on dopaminergic neuronal activity, the noradrenergic and serotoninergic neurotoxins DSP-4 N-(2-chlorethyl)-N-ethyl-2-bromobenzylamine (50.0 mg/kg, sc) and 5,7- dihydroxytryptamine (5,7-DHT) (37.5 μg icv, half in each lateral ventricle), respectively, were administered toWistar rats on the first and third days of postnatal ontogeny, and dopamine (DA) agonist-induced behaviors were assessed in adulthood. At eight weeks, using an HPLC/ED technique, DSP-4 treatment was associated with a reduction in NE content of the corpus striatum (> 60%), hippocampus (95%), and frontal cortex (> 85%), while 5,7-DHT was associated with an 80–90% serotonin reduction in the same brain regions. DA content was unaltered in the striatum and the cortex. In the group lesioned with both DSP-4 and 5,7-DHT, quinpirole-induced (DA D?? agonist) yawning, 7-hydroxy-DPAT-induced (DA D agonist) yawning, and apomorphine-induced (non-selective DAagonist) stereotypies were enhanced. However, SKF 38393-induced (DAD agonist) oral activity was reduced in the DSP-4 + 5,7-DHT group. These findings demonstrate that DA D??- and D -agonist-induced behaviors are enhanced while DA D -agonist-induced behaviors are suppressed in adult rats in which brain noradrenergic and serotoninergic innervation of the brain has largely been destroyed. This study indicates that noradrenergic and serotoninergic neurons have a great impact on the development of DA receptor reactivity (sensitivity).
机译:为了评估去甲肾上腺素能和5-羟色胺能神经元对多巴胺能神经元活性的可能调节作用,去甲肾上腺素能和5-羟色胺能神经毒素DSP-4 N-(2-氯乙基)-N-乙基-2-溴苄胺(50.0 mg / kg,sc)和5,在出生后第一天和第三天分别对Wistar大鼠施用7-二羟色胺(5,7-DHT)(37.5μgicv,每个侧脑室一半),并评估多巴胺(DA)激动剂诱导的行为。成年。在八周的时间里,采用HPLC / ED技术,DSP-4治疗可减少纹状体NE(> 60%),海马(95%)和额叶皮层(> 85%)NE含量,而5在同一大脑区域,-7-DHT与5-羟色胺减少80-90%相关。纹状体和皮质中的DA含量未改变。在受DSP-4和5,7-DHT损伤的组中,喹吡罗诱导的(DADβ激动剂)打呵欠,7-羟基-DPAT诱导的(DA D激动剂)打呵欠和阿扑吗啡诱导的(非选择性) DAagonist)的定型观念得到了增强。但是,在DSP-4 + 5,7-DHT组中,SKF 38393诱导的(DAD激动剂)口服活性降低。这些发现表明,在成年大鼠中,DADβ-和D-激动剂诱导的行为得到增强,而DA D-激动剂诱导的行为被抑制,其中脑的去甲肾上腺素能和5-羟色胺能神经支配已被破坏。这项研究表明,去甲肾上腺素能和5-羟色胺能神经元对DA受体反应性(敏感性)的发展有很大的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号